These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1454064)

  • 1. Expression of the V(D)J recombinase gene RAG-1 is tightly regulated and involves both transcriptional and post-transcriptional controls.
    Neale GA; Fitzgerald TJ; Goorha RM
    Mol Immunol; 1992 Dec; 29(12):1457-66. PubMed ID: 1454064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAG-1 and RAG-2 gene expression and V(D)J recombinase activity are enhanced by protein phosphatase 1 and 2A inhibition in lymphocyte cell lines.
    Casillas AM; Thompson AD; Cheshier S; Hernandez S; Aguilera RJ
    Mol Immunol; 1995 Feb; 32(3):167-75. PubMed ID: 7898493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A V(D)J recombinase-inducible B-cell line: role of transcriptional enhancer elements in directing V(D)J recombination.
    Oltz EM; Alt FW; Lin WC; Chen J; Taccioli G; Desiderio S; Rathbun G
    Mol Cell Biol; 1993 Oct; 13(10):6223-30. PubMed ID: 8413222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination.
    Oettinger MA; Schatz DG; Gorka C; Baltimore D
    Science; 1990 Jun; 248(4962):1517-23. PubMed ID: 2360047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymocyte expression of RAG-1 and RAG-2: termination by T cell receptor cross-linking.
    Turka LA; Schatz DG; Oettinger MA; Chun JJ; Gorka C; Lee K; McCormack WT; Thompson CB
    Science; 1991 Aug; 253(5021):778-81. PubMed ID: 1831564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function and control of recombination-activating gene activity.
    Alt FW; Rathbun G; Oltz E; Taccioli G; Shinkai Y
    Ann N Y Acad Sci; 1992 May; 651():277-94. PubMed ID: 1599127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two waves of recombinase gene expression in developing thymocytes.
    Wilson A; Held W; MacDonald HR
    J Exp Med; 1994 Apr; 179(4):1355-60. PubMed ID: 8145048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin gene hypermutation in germinal centers is independent of the RAG-1 V(D)J recombinase.
    Zheng B; Han S; Spanopoulou E; Kelsoe G
    Immunol Rev; 1998 Apr; 162():133-41. PubMed ID: 9602359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemic cells.
    Sherman ML; Stone RM; Datta R; Bernstein SH; Kufe DW
    J Biol Chem; 1990 Feb; 265(6):3320-3. PubMed ID: 2105946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 mRNA levels and degradation rates change with mode of stimulation and phorbol ester treatment of lymphocytes.
    Bill O; Garlisi CG; Grove DS; Holt GE; Mastro AM
    Cytokine; 1994 Jan; 6(1):102-10. PubMed ID: 8003628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The V(D)J recombination activating gene, RAG-1.
    Schatz DG; Oettinger MA; Baltimore D
    Cell; 1989 Dec; 59(6):1035-48. PubMed ID: 2598259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phorbol ester exposure activates an AP-1-mediated increase in ERCC-1 messenger RNA expression in human ovarian tumor cells.
    Li Q; Zhang L; Tsang B; Gardner K; Bostick-Bruton F; Reed E
    Cell Mol Life Sci; 1999 Mar; 55(3):456-66. PubMed ID: 10228559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DDE motif in RAG-1 is contributed in trans to a single active site that catalyzes the nicking and transesterification steps of V(D)J recombination.
    Swanson PC
    Mol Cell Biol; 2001 Jan; 21(2):449-58. PubMed ID: 11134333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paleo-immunology: evidence consistent with insertion of a primordial herpes virus-like element in the origins of acquired immunity.
    Dreyfus DH
    PLoS One; 2009 Jun; 4(6):e5778. PubMed ID: 19492059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered topoisomerase I activity and recombination activating gene expression in a human leukemia cell line resistant to doxorubicin.
    Riou JF; Grondard L; Petitgenet O; Abitbol M; Lavelle F
    Biochem Pharmacol; 1993 Sep; 46(5):851-61. PubMed ID: 8396937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of IL-7 V(D)J recombination.
    Döbbeling U
    Immunology; 1996 Dec; 89(4):569-72. PubMed ID: 9014823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transcriptional regulation of granulocyte-macrophage colony-stimulating factor synthesis in murine T cells.
    Bickel M; Cohen RB; Pluznik DH
    J Immunol; 1990 Aug; 145(3):840-5. PubMed ID: 2197329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rch1, a protein that specifically interacts with the RAG-1 recombination-activating protein.
    Cuomo CA; Kirch SA; Gyuris J; Brent R; Oettinger MA
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6156-60. PubMed ID: 8016130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate.
    Saceda M; Knabbe C; Dickson RB; Lippman ME; Bronzert D; Lindsey RK; Gottardis MM; Martin MB
    J Biol Chem; 1991 Sep; 266(27):17809-14. PubMed ID: 1917923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional modulation of the human complement factor I gene in Hep G2 cells by protein kinase C activation.
    Minta J; Fung M
    Mol Cell Biochem; 1999 Nov; 201(1-2):111-23. PubMed ID: 10630630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.